British Association of Dermatologists: guidelines for the management of squamous cell carcinoma in situ (Bowen disease)
British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma in situ (Bowen disease) 2022
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of squamous cell carcinoma (SCC) in situ. The document aims to:
- offer an appraisal of all relevant literature up to 13 August 2021, focusing on any key developments
- address important, practical clinical questions relating to the primary guideline objective
- provide guideline recommendations and if appropriate research recommendations.
The guideline is presented as a detailed review with highlighted recommendations for practical use in primary care and in the clinic.
The guideline also reviews erythroplasia of Queyrat/penile intraepithelial neoplasia and Bowenoid papulosis, which have similar histology and are often diagnosed by dermatologists. However, detailed therapeutic review of these conditions is beyond the scope of this guideline and readers are directed to recent review articles for further information: Kravvas et al.1 and Issa et al.2
Read full guideline